Summary
The authors found that oxyphenbutazone (Tanderil®) added to culture medium, in amounts giving a final concentration of 10–100 μg/ml, causes a decrease in the liberation of fibrinolytic agents from explants of various tissues cultured in vitro.
Similar content being viewed by others
References
A. Fischer,Gewebezüchtung (Miller & Steinicke Verlag, München 1930).
I. Santesson, Acta path. microbiol. scand., suppl.24 (1935).
M. Bernik andH. C. Kwann, J. clin. Invest.48, 1740 (1969).
B. åstedt andM. Pandolfi, Eur. J. clin. Biol. Res.17, 261 (1972).
B. Åstedt, M. Pandolfi andI. M. Nilsson, Proc. Soc. exp. Biol. Med.139, 1420 (1972).
B. Åstedt, M. Pandolfi andI. M. Nilsson, Experientia27, 358 (1971).
I. M. Nilsson andS. Isacson, Progr. Surg.11, 46 (1973).
V. A. Donaldson, inSeries Haematologica (Eds.K. G. Jensen andS. Killman; Munksgaard, Copenhagen 1970), vol. 3, p. 39.
T. Astrup, Biochem. Pharmac. suppl.241 (1968).
J. E. Niléhn, Thromb. Diath. haemorrh.18, 487 (1967).
M. Pandolfi, B. Åstedt andI. M. Nilsson, Thromb. Diath. haemorrh.31, 415 (1974).
B. Henricson andT. Astrup, Lab. Invest.30, 427 (1974).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pandolfi, M., Dyster-Aas, K. & Åstedt, B. Antifibrinolytic properties of oxyphenbutazone in vitro. Experientia 32, 209–210 (1976). https://doi.org/10.1007/BF01937769
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01937769